tiprankstipranks
Cannara Biotech (LOVFF)
OTHER OTC:LOVFF
US Market
Holding LOVFF?
Track your performance easily

Cannara Biotech (LOVFF) Financial Statements

10 Followers

Cannara Biotech Financial Overview

Cannara Biotech's market cap is currently ―. The company's EPS TTM is $0.051; its P/E ratio is ―; Cannara Biotech is scheduled to report earnings on January 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24May 24Feb 24Nov 23Aug 23
Income Statement-
Total Revenue$ 7.89M$ 27.56M$ 27.21M$ 19.48M$ 18.28M
Gross Profit$ -8.81M$ 13.77M$ 14.67M$ 7.94M$ 6.89M
EBIT$ 5.32M$ 3.55M$ -3.45M$ 3.49M$ 6.29M
EBITDA$ 7.09M$ 5.07M$ -1.99M$ 5.11M$ 7.61M
Net Income Common Stockholders$ 5.75M$ 2.02M$ -3.45M$ 2.11M$ 4.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.62M$ 5.46M$ 3.13M$ 2.64M$ 4.27M
Total Assets$ 154.72M$ 148.77M$ 145.82M$ 144.82M$ 141.52M
Total Debt$ 42.07M$ 42.62M$ 42.95M$ 42.15M$ 41.78M
Net Debt$ 35.45M$ 37.16M$ 39.82M$ 39.52M$ 37.51M
Total Liabilities$ 66.77M$ 67.00M$ 66.48M$ 62.96M$ 61.78M
Stockholders Equity$ 87.95M$ 81.77M$ 79.34M$ 81.86M$ 79.74M
Cash Flow-
Free Cash Flow$ 180.17K$ 6.35M$ 1.22M$ -2.41M$ 1.18M
Operating Cash Flow$ 3.67M$ 4.33M$ 2.33M$ 354.22K$ 2.84M
Investing Cash Flow$ -436.19K$ -944.20K$ -1.08M$ -2.73M$ -1.63M
Financing Cash Flow$ -2.08M$ -1.05M$ -768.49K$ 747.32K$ -973.30K
Currency in USD

Cannara Biotech Earnings and Revenue History

Cannara Biotech Debt to Assets

Cannara Biotech Cash Flow

Cannara Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis